Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Manitoba

$25,000.00

Optimization of Dispersin B production in Escherichia coli.

FY 2017-18

Summary
Kane Biotech Inc. is a Manitoba-based company that provides innovative technologies that break down anddisperse microbial biofilms. Its mission is to discover and commercialize new technologies that will preventbiofilm-related infections in human and animal healthcare, as well as biofilm-related industrial applications.Dispersin B has been shown to both inhibit and disperse bacterial biofilms. Kane Biotech Inc. has expressedthis enzyme protein in E. coli, with the goal of developing Dispersin B-based products. Dispersin B yield andthe cost effective commercial production of the enzyme are critical factors affecting the market opportunitiesfor Kane Biotech's Dispersin B products, estimated to be $10 million in the next few years. Kane Biotech willpartner with Dr. David Levin, in the Department of Biosystems Engineering at the University of Manitoba, in ajoint research project to optimize production of Dispersin B. The specific goals of the proposed research are toidentify an animal-product-free (APF) cell culture medium that supports maximal cell mass production andDispersin B yields, and develop a scale-up fermentation process using the best APF medium in a bioreactorsystem.
Program
Engage Grants Program
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
513745-2017
Name nom
Levin, David
Department département
Biosystems Engineering
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Optimization of Dispersin B production in Escherichia coli.
Keyword
NSERC
Application summary
Kane Biotech Inc. is a Manitoba-based company that provides innovative technologies that break down anddisperse microbial biofilms. Its mission is to discover and commercialize new technologies that will preventbiofilm-related infections in human and animal healthcare, as well as biofilm-related industrial applications.Dispersin B has been shown to both inhibit and disperse bacterial biofilms. Kane Biotech Inc. has expressedthis enzyme protein in E. coli, with the goal of developing Dispersin B-based products. Dispersin B yield andthe cost effective commercial production of the enzyme are critical factors affecting the market opportunitiesfor Kane Biotech's Dispersin B products, estimated to be $10 million in the next few years. Kane Biotech willpartner with Dr. David Levin, in the Department of Biosystems Engineering at the University of Manitoba, in ajoint research project to optimize production of Dispersin B. The specific goals of the proposed research are toidentify an animal-product-free (APF) cell culture medium that supports maximal cell mass production andDispersin B yields, and develop a scale-up fermentation process using the best APF medium in a bioreactorsystem.